Compile Data Set for Download or QSAR
maximum 50k data
Found 16 of ki for UniProtKB: Q05586
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557699(US11358971, Compound 1h | US11466027, Compound 1l)
Affinity DataKi:  63nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557694(US11358971, Compound 1c | US11466027, Compound 1e)
Affinity DataKi:  96nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557693(US11358971, Compound 1b | US11466027, Compound 1d)
Affinity DataKi:  140nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557667(US11358971, Compound 1a | US11466027, Compound 1c)
Affinity DataKi:  170nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557701(US11358971, Compound 1j | US11466027, Compound 1n)
Affinity DataKi:  180nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM576021((R)-2-amino-3-[(7- isopropylthieno[3,2- b]pyridine...)
Affinity DataKi:  220nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557698(US11358971, Compound 1g | US11466027, Compound 1k)
Affinity DataKi:  220nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557702(US11358971, Compound 1k | US11466027, Compound 1o)
Affinity DataKi:  260nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM576017((R)-2-amino-3-[(7- ethylthieno[3,2-b]pyridine- 2- ...)
Affinity DataKi:  270nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557697(US11358971, Compound 1f | US11466027, Compound 1i)
Affinity DataKi:  360nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557703(US11358971, Compound 1l | US11466027, Compound 1p)
Affinity DataKi:  490nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557696(US11358971, Compound 1e | US11466027, Compound 1h)
Affinity DataKi:  690nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557695(US11358971, Compound 1d | US11466027, Compound 1g)
Affinity DataKi:  860nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM576026((R)-2-amino-3-[(7- ethoxythieno[3,2- b]pyridine-2-...)
Affinity DataKi:  870nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557700(US11358971, Compound 1i | US11466027, Compound 1m)
Affinity DataKi:  3.90E+3nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM575980((R)-2-amino-3-[[7- thieno[3,2-b]pyridine-2- carbon...)
Affinity DataKi:  7.40E+3nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent